DLH Named Corporate Growth Award Finalist

  DLH has been named a Corporate Growth Award finalist…

Experts Come Together for Third Annual DLH TBI/PTSD Consortium Conference

DLH leaders were joined by researchers, educators, clinicians,…

DLH-Supported Projects Named 2021 FedHealthIT Innovation Award Winners

Three DLH-supported projects have been named 2021 FedHealthIT Innovation Award winners. The recognized programs are the National Emergency Tele-Critical Care Network (“NETCCN”), the Department of Veterans Affairs (VA) Logistics Redesign (“VALOR”), and the Individual Longitudinal Exposure Record (“ILER”).

DLH Named One of the Fastest-Growing Companies in Georgia

DLH has been named one of the fastest-growing companies in…

DLH Wins Follow-On Contract for CMOP Medical Logistics for the Department of Veterans Affairs

Atlanta, Georgia – April 23, 2021 - DLH Holdings Corp. (NASDAQ:…

DLH Re-Awarded Health Care Staffing Services Certification from The Joint Commission

DLH Corporation has again earned The Joint Commission’s Gold Seal of Approval® for Health Care Staffing Services (HCSS) Certification by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care.
Two researchers at a microscope.

DLH Wins Renewal of Clinical Support to NIH-Funded AIDS Clinical Trials Group (ACTG)

DLH today announced that it has been awarded a contract to continue operating the AIDS Clinical Trials Group’s (ACTG) Network Coordinating Center (NCC).
Financial News

DLH Reports Fourth Quarter and Fiscal Year 2020 Results

ATLANTA, Dec. 07, 2020 -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH”…

DLH Team Member Wins FedHealthIT100 Award

DLH team member Stan Adamus has been named a FedHealthIT100 2021 Award winner! The award honors individuals who drove change and innovation, challenged conventional wisdom, and gave back to the larger federal health community in the past year.

DLH Appoints Chief Scientist

Sandra Halverson, MPH, PhD has been appointed Chief Scientist effective November 1, 2020. In this role, Dr. Halverson will work collaboratively with the DLH Executive Leadership Team to help set company research and scientific priorities.